25
Clinical Manifests
100+
Safety Triggers
16
Anatomical Points
13
Drug Interactions

The Operating System
for Peptide Research

Built on 25 Clinical Manifests, 100+ Safety Triggers,and 16-Point Anatomical Precision.

THE BRAIN

Clinical Logic
Under the Hood

Every recommendation passes through our Safety Engine - a rule-based system built on peer-reviewed research and clinical protocols.

Fatal
Warning
Caution
safety-engine.ts
// if (GHS + History of Cancer) {
return { BLOCK }
}

Growth hormone secretagogues can accelerate malignant cell proliferation

// if (Route === "IV" && Peptide === "Ipamorelin") {
return { FATAL RISK }
}

IV administration causes rapid cardiovascular collapse

// if (Metformin + MOTS-c) {
return { AMPK OVERLAP WARNING }
}

Both compounds activate AMPK pathway - monitor for hypoglycemia

// if (ContinuousUse > 84 days) {
return { ENFORCE WASHOUT }
}

Pituitary desensitization requires 4-6 week recovery period

// if (SSRIs + Semax) {
return { SEROTONIN SYNDROME RISK }
}

Semax modulates serotonergic signaling - concurrent use requires monitoring

BIMODAL PRECISION

One Dose.
Every Hardware.

Whether you use a 0.3mL insulin syringe or a 1.0mL standard syringe, we calculate the exact draw volume to the hundredth of a unit.

0.3mL
Insulin Syringe
051015202530
0 units
= 300mcg dose
1.0mL
Standard Syringe
0102030405060708090100
0 units
= 300mcg dose
Pen Device
Click-Dial Dosing
0clicks
0mcg
@ 50mcg per click

Same reconstitution (5mg in 2mL BAC water) = Same dose (300mcg) = Different draw volumes.
The math is done for you.

GLOBAL SAFETY GUARD

100+ Triggers.
Zero Blind Spots.

Every flag below is actively monitored. Drug interactions, contraindications, scheduling conflicts - we've closed the 2% gap that other apps ignore.

Fatal/Cancer
Warning
Drug Interaction
Scheduling
IV Ipamorelin
→ Cardiovascular Collapse
Critical Illness + GHRP-2
→ Multi-Organ Failure
Active Malignancy + IGF-1 Peptides
→ Tumor Progression
Melanocytic Lesions + Melanotan
→ Melanoma Acceleration
Lynch Syndrome + CJC-1295
→ Colorectal Cancer Risk
High Immunogenicity + Repeated Use
→ Antibody Formation
SSRIs + Semax
→ Serotonin Syndrome Risk
Insulin + GLP-1 Agonists
→ Severe Hypoglycemia
Beta Blockers + Ipamorelin
→ Bradycardia Risk
NSAIDs + TB-500
→ Reduced Efficacy
ACE Inhibitors + AOD-9604
→ Hypotension Risk
Anticoagulants + Epithalon
→ Bleeding Risk
GH Secretagogue < 2hr Post-Meal
→ Blunted Release
DSIP + Daytime Administration
→ Drowsiness Risk
Pulsing Protocol Violation
→ Pituitary Fatigue
IV Ipamorelin
→ Cardiovascular Collapse
Critical Illness + GHRP-2
→ Multi-Organ Failure
Active Malignancy + IGF-1 Peptides
→ Tumor Progression
Melanocytic Lesions + Melanotan
→ Melanoma Acceleration
Lynch Syndrome + CJC-1295
→ Colorectal Cancer Risk
High Immunogenicity + Repeated Use
→ Antibody Formation
SSRIs + Semax
→ Serotonin Syndrome Risk
Insulin + GLP-1 Agonists
→ Severe Hypoglycemia
Beta Blockers + Ipamorelin
→ Bradycardia Risk
NSAIDs + TB-500
→ Reduced Efficacy
ACE Inhibitors + AOD-9604
→ Hypotension Risk
Anticoagulants + Epithalon
→ Bleeding Risk
GH Secretagogue < 2hr Post-Meal
→ Blunted Release
DSIP + Daytime Administration
→ Drowsiness Risk
Pulsing Protocol Violation
→ Pituitary Fatigue
IV Ipamorelin
→ Cardiovascular Collapse
Critical Illness + GHRP-2
→ Multi-Organ Failure
Active Malignancy + IGF-1 Peptides
→ Tumor Progression
Melanocytic Lesions + Melanotan
→ Melanoma Acceleration
Lynch Syndrome + CJC-1295
→ Colorectal Cancer Risk
High Immunogenicity + Repeated Use
→ Antibody Formation
SSRIs + Semax
→ Serotonin Syndrome Risk
Insulin + GLP-1 Agonists
→ Severe Hypoglycemia
Beta Blockers + Ipamorelin
→ Bradycardia Risk
NSAIDs + TB-500
→ Reduced Efficacy
ACE Inhibitors + AOD-9604
→ Hypotension Risk
Anticoagulants + Epithalon
→ Bleeding Risk
GH Secretagogue < 2hr Post-Meal
→ Blunted Release
DSIP + Daytime Administration
→ Drowsiness Risk
Pulsing Protocol Violation
→ Pituitary Fatigue
Sauna + Alcohol + GH Secretagogues
→ Hypotensive Crisis
Tesamorelin + Acute Infection
→ Septic Shock Risk
MEN 2 Syndrome + GLP-1 Agonists
→ Medullary Thyroid Cancer
History of Cancer + Growth Hormone
→ Recurrence Risk
Bovine Sensitivity + TB-500
→ Allergic Reaction
Metformin + MOTS-c
→ AMPK Pathway Overlap
SNRIs + Selank
→ Serotonergic Interaction
Warfarin + Semaglutide
→ Altered Gastric Emptying
Corticosteroids + BPC-157
→ Healing Interference
Thyroid Meds + Tesamorelin
→ TSH Suppression
Statins + MOTS-c
→ Myopathy Risk
Immunosuppressants + Thymalin
→ Immune Dysregulation
CJC-1295 + Morning Cortisol
→ Suboptimal Timing
BPC-157 > 12 Weeks Continuous
→ Receptor Downregulation
Metabolic Class Switch < 90 Days
→ Washout Violation
Sauna + Alcohol + GH Secretagogues
→ Hypotensive Crisis
Tesamorelin + Acute Infection
→ Septic Shock Risk
MEN 2 Syndrome + GLP-1 Agonists
→ Medullary Thyroid Cancer
History of Cancer + Growth Hormone
→ Recurrence Risk
Bovine Sensitivity + TB-500
→ Allergic Reaction
Metformin + MOTS-c
→ AMPK Pathway Overlap
SNRIs + Selank
→ Serotonergic Interaction
Warfarin + Semaglutide
→ Altered Gastric Emptying
Corticosteroids + BPC-157
→ Healing Interference
Thyroid Meds + Tesamorelin
→ TSH Suppression
Statins + MOTS-c
→ Myopathy Risk
Immunosuppressants + Thymalin
→ Immune Dysregulation
CJC-1295 + Morning Cortisol
→ Suboptimal Timing
BPC-157 > 12 Weeks Continuous
→ Receptor Downregulation
Metabolic Class Switch < 90 Days
→ Washout Violation
Sauna + Alcohol + GH Secretagogues
→ Hypotensive Crisis
Tesamorelin + Acute Infection
→ Septic Shock Risk
MEN 2 Syndrome + GLP-1 Agonists
→ Medullary Thyroid Cancer
History of Cancer + Growth Hormone
→ Recurrence Risk
Bovine Sensitivity + TB-500
→ Allergic Reaction
Metformin + MOTS-c
→ AMPK Pathway Overlap
SNRIs + Selank
→ Serotonergic Interaction
Warfarin + Semaglutide
→ Altered Gastric Emptying
Corticosteroids + BPC-157
→ Healing Interference
Thyroid Meds + Tesamorelin
→ TSH Suppression
Statins + MOTS-c
→ Myopathy Risk
Immunosuppressants + Thymalin
→ Immune Dysregulation
CJC-1295 + Morning Cortisol
→ Suboptimal Timing
BPC-157 > 12 Weeks Continuous
→ Receptor Downregulation
Metabolic Class Switch < 90 Days
→ Washout Violation
30
Active Safety Monitors
ANATOMICAL PRECISION

16-Point Rotation Grid

User sovereignty means you control which sites are active. Exclude injured areas, set preferences, and let the rotation engine do the rest.

Front Zones

Deltoids
SubQ / IM compatible
2/2
sites
Abdomen
SubQ compatible
0/4
sites
Thighs
SubQ / IM compatible
2/4
sites
Total Active Sites4/18
Symmetrical Pair Logic
Tap one side, both activate. Long-press to disable individual sites for injuries.
OPEN SOURCE LOGIC

Logic Explorer

Built with Transparency. No Black-Box Logic.
Only Research-Backed Precision.

Drug-Peptide Interaction Check

safety-guard.ts + drug-interactions.ts

// Drug-Peptide Interaction Check
checkDrugInteractions(400">profile: 400">UserProfile, 400">peptideIds: 400">string[]): 400">DrugInteractionMatch[] {
  400">const 400">matches: 400">DrugInteractionMatch[] = []
  400">for (400">const interaction 400">of DRUG_INTERACTIONS) {
    400">const userHasDrug = this.userHasMedication(profile, interaction.drugKey)
    400">if (!userHasDrug) continue
    400">for (400">const peptideId 400">of peptideIds) {
      400">if (interaction.conflictingPeptides.includes(peptideId)) {
        matches.push({
          interaction,
          400">userDrug: interaction.drugName,
          400">conflictingPeptide: peptideId,
          400">severity: interaction.severity,
        })
      }
    }
  }
  400">return matches
}
// Example Interaction Data
{
  400">drugName: 400">'Insulin',
  400">conflictingPeptides: [400">'semaglutide', 400">'tirzepatide'],
  400">mechanism: 400">'Increased risk 400">of severe hypoglycemia',
  400">severity: 400">'critical',
}

All logic is auditable. No hidden algorithms. No proprietary black boxes.